The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.
November 14th 2024
A new analysis highlights the seasonal patterns of airborne fungal spores that can be found in the central region of England, with a calendar developed to this same end.
Gut Micriobiome and Its Role in Allergy and Asthma
One of the hottest topics in medical science today is the role of the gut microbiome and its affect on various aspects of a person's health. A recent study looked at whether it can help predict the likelihood of a child having health issues linked to allergy and asthma.
Common Cold and Exacerbating Asthma Conditions
For children going to school, their time in the classroom is a time of learning but also a time when germs can be spread on a wide scale basis. For asthma patients this can often mean several causes of their condition becoming worse without having done much to cause it.
Continued Research Shows New Options for Early Peanut Allergy Issues
It was only a few short years ago that pediatricians were advising new parents to avoid giving their children peanuts for fear of triggering an allergic reaction. That may not be the case anymore thanks to recent detailed studies on the topic.
New Prescriptions, Costs Present Challenges for Allergists Part 2
There seems to be an ever growing list of items people are allergic to, and allergies that would only last a matter of months now stretch throughout the calendar for many. How best to handle these patients has become a focal point of care for allergists.
Providing Needed Care to Inner City Asthma Patients
In the inner cities some children do not have the resources at their disposal to get the care they needed. Recently considerable effort has been made to helping keep them healthy and able to function in their daily lives.
The US Food and Drug Administration (FDA)Wednesday announced the approval of Teva's albuterol sulfate inhalation powder (ProairRespiClick), a breath-actuated, multi-dose, dry-powder, short-acting beta-agonist (SABA) inhaler for treating or preventing bronchospasm in patients 12 years and older suffering from reversible obstructive airway disease and for preventing exercise-induced bronchospasm (EIB) in patients 12 years and older.
COPD and Smoking Are Tied to Increased Risk of Osteoporosis, Fractures
March 24th 2015Current osteoporosis guidelines don't recommend screening for men. However, researchers from National Jewish Health have identified men's smoking history and chronic obstructive pulmonary disease (COPD) as risk factors for osteoporosis and fractures of the vertebrae.
Cystic Fibrosis Discovery Provides Insight into Other Pulmonary Conditions
March 24th 2015In patients with cystic fibrosis, the mucus molecular bonds become more complex due to inflammation, creating an "elastic sludge" effect, according to a team of researchers from University of California San Francisco who claimed their findings could also be beneficial for other respiratory conditions such as COPD and asthma.
Second Study Confirms Flu Vaccine Does Not Cause Noteworthy Reaction in Egg Allergic Children
A second trial of intranasal flu vaccines in children with egg allergies has reached the same conclusion as the first: The trace amounts of egg protein do not trigger systemic reactions such as anaphylaxis.
Tiotropium Improves Lung Function, Regardless of Allergic Status, Study Reports
Adding tiotropium Respimat treatment in adult patients with mild, moderate, and severe asthma who continue to experience symptoms despite the use of maintenance therapies significantly improved lung function, according to a presentation by Boehringer Ingelheim scientists at the 2015 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Houston, TX.